CM
Insider
Christopher Mutz
HEAD OF RARE DISEASEChristopher Mutz (HEAD OF RARE DISEASE) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $538K of ANIP (7,032 sh × $76.55, as filed), executed Feb 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.6M
shares × price, as filed
Last traded
Mar 13
Filed Mar 13
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$227K3,162 sh × $71.64
Exec Mar 13
Filed Mar 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $425K
5,723 sh across 2 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $415K
5,323 sh × $78.02
Exec Feb 20
Filed Feb 23 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $538K
7,032 sh × $76.55
Exec Feb 12
Filed Feb 17 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $242K
4,000 sh × $60.45
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $375K
6,500 sh × $57.70
Exec Nov 15 2024
Filed Nov 18 2024 · 5:30 PM ET